Corporate Adviser
  • Content Hubs
  • Magazine
  • Alerts
  • Events
  • Video
    • Master Trust Conference 2024 videos
  • Research & Guides
  • About
  • Contact
  • Home
  • News
  • In Depth
  • Profile
  • Pensions
    • Auto-enrolment
    • DB
    • DC
    • Defaults
    • Investment
    • Master Trusts
    • Sipps & SSAS
    • Taxation
  • Group Risk
    • Group Life
    • Group IP
    • Group CIC
    • Mental Health
    • Rehab
    • Wellbeing
  • Healthcare
    • Musculoskeletal
    • Mental Health
    • IPT
    • Wellbeing
    • Trusts
    • Cash Plans
  • Wellbeing
    • Mental Health
    • Health & Wellbeing
    • Financial resilience
  • ESG
No Result
View All Result
Corporate Adviser
No Result
View All Result

Reframe Cancer appoints non-executive director from health insurance industry

by Emma Simon
November 1, 2024
Share on FacebookShare on TwitterShare on LinkedInShare on Pinterest

Reframe Cancer, which works with a number of insurers, has appointed Jenni Wilson as a non-executive director as it looks to further grow the business.

Wilson has over 30 years’ commercial expertise in health insurance, hospitals and healthcare, having held director roles at Bupa, Axa, Nuffield Health and Simplyhealth, Denplan.  

Reframe Cancer provides cancer navigation and support to a wide range of insurers including Unum, Lime Health, Pulse Insurance and employers such as  Meta and Salesforce. It has experienced a period of rapid growth in 2024 with a number of new direct partnerships.

Reframe Cancer CEO Mark Stephenson says this appointment will help ensure the company continues to serve the evolving needs of insurers, brokers, and providers. He adds: “With [Wilson] on board, we’re now better equipped to deliver tailored solutions that meet the unique requirements of each segment.”

Wilson says: “The need for high quality support products for insurers, providers, employees and patients impacted by cancer has never been more important, especially with cancer rates rising amongst younger people. 

“Reframe Cancer are trusted cancer experts who complement and enhance clinical plans, helping people to navigate their individual cancer journeys.” She said she hoped her experience and expertise would enable the company to continue to deliver new products and continue to grow as a business. 

Corporate Adviser Special Report

REQUEST YOUR COPY

Most Popular

  • NatWest Cushon ‘up for sale’ – media reports

  • Jamie Jenkins: Fiscal and political dangers of reducing tax-free cash from pensions

  • HCML launches healthcare master trust

  • GLP-1 drugs could cut UK mortality by 5.1pc by 2045: Swiss Re

  • Aviva partners with suicide prevention charity

  • Bupa names Chris Carroll as global, India & UK CEO

Corporate Adviser

© 2017-2024 Definite Article Media Limited. Design by 71 Media Limited.

  • About
  • Advertise
  • Privacy policy
  • T&Cs
  • Contact

Follow Us

X
No Result
View All Result
  • Home
  • News
  • In Depth
  • Profile
  • Pensions
    • Auto-enrolment
    • DB
    • DC
    • Defaults
    • Investment
    • Master Trusts
    • Sipps & SSAS
    • Taxation
  • Group Risk
    • Group Life
    • Group IP
    • Group CIC
    • Mental Health
    • Rehab
    • Wellbeing
  • Healthcare
    • Musculoskeletal
    • Mental Health
    • IPT
    • Wellbeing
    • Trusts
    • Cash Plans
  • Wellbeing
    • Mental Health
    • Health & Wellbeing
    • Financial resilience
  • ESG

No Result
View All Result
  • Home
  • News
  • In Depth
  • Profile
  • Pensions
    • Auto-enrolment
    • DB
    • DC
    • Defaults
    • Investment
    • Master Trusts
    • Sipps & SSAS
    • Taxation
  • Group Risk
    • Group Life
    • Group IP
    • Group CIC
    • Mental Health
    • Rehab
    • Wellbeing
  • Healthcare
    • Musculoskeletal
    • Mental Health
    • IPT
    • Wellbeing
    • Trusts
    • Cash Plans
  • Wellbeing
    • Mental Health
    • Health & Wellbeing
    • Financial resilience
  • ESG

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.